Primary cilia formation requires the Leigh syndrome–associated mitochondrial protein NDUFAF2
Journal of Clinical Investigation · 01.07.2024 · 134 (13)
DOI: 10.1172/jci175560 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.07.2024. Verfasst von Chien-Hui Lo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Zebrafish, Leigh Disease, Cilia, Mitochondria. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, NIH Office of the Director.
Abstract (Originalsprache)
Mitochondria-related neurodegenerative diseases have been implicated in the disruption of primary cilia function. Mutation in an intrinsic mitochondrial complex I component NDUFAF2 has been identified in Leigh syndrome, a severe inherited mitochondriopathy. Mutations in ARMC9 , which encodes a basal body protein, cause Joubert syndrome, a ciliopathy with defects in the brain, kidney, and eye. Here, we report a mechanistic link between mitochondria metabolism and primary cilia signaling. We discovered that loss of NDUFAF2 caused both mitochondrial and ciliary defects in vitro and in vivo and identified NDUFAF2 as a binding partner for ARMC9. We also found that NDUFAF2 was both necessary and sufficient for cilia formation and that exogenous expression of NDUFAF2 rescued the ciliary and mitochondrial defects observed in cells from patients with known ARMC9 deficiency. NAD + supplementation restored mitochondrial and ciliary dysfunction in ARMC9-deficient cells and zebrafish and ameliorated the ocular motility and motor deficits of a patient with ARMC9 deficiency. The present results provide a compelling mechanistic link, supported by evidence from human studies, between primary cilia and mitochondrial signaling. Importantly, our findings have significant implications for the development of therapeutic approaches targeting ciliopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.
- Department of Medicine, Stanford University, Palo Alto, California, USA.
- Institute of Biochemistry and Molecular Biology, College of Life Science, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Palo Alto Veterans Administration, Palo Alto, California, USA.
- Stanford Maternal and Child Health Research Institute and.
- BioX, Stanford University School of Medicine, Palo Alto, California, USA.
Förderung
- NEI NIH HHS
- NIH HHS
- NIH Office of the Director
- Office of Academic Affiliations, Department of Veterans Affairs
Zitieren
APA
Lo, C. H., Liu, Z., Chen, S., Lin, F., Berneshawi, A. R., Yu, C. Q., Koo, E. B., Kowal, T. J., Ning, K., Hu, Y., Wang, W. J., Liao, Y. J., & Sun, Y. (2024). Primary cilia formation requires the Leigh syndrome–associated mitochondrial protein NDUFAF2. Journal of Clinical Investigation, 134(13). https://doi.org/10.1172/jci175560
Vancouver
Lo CH, Liu Z, Chen S, Lin F, Berneshawi AR, Yu CQ, et al. Primary cilia formation requires the Leigh syndrome–associated mitochondrial protein NDUFAF2. Journal of Clinical Investigation. 2024;134(13). doi:10.1172/jci175560
BibTeX
@article{Lo2024,
author = {Lo, Chien-Hui and Liu, Zhiquan and Chen, Siyu and Lin, Frank and Berneshawi, Andrew R and Yu, Charles Q and Koo, Euna B and Kowal, Tia J and Ning, Ke and Hu, Yang and Wang, Won-Jing and Liao, Y Joyce and Sun, Yang},
title = {Primary cilia formation requires the Leigh syndrome–associated mitochondrial protein NDUFAF2},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {13},
doi = {10.1172/jci175560}
}
EUVIMED